Yüklüyor......

Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?

There is a significant opportunity to improve cardiovascular disease (CVD) outcomes in lung cancer screening cohorts with a low-cost, noninvasive assessment of CVD risk, alongside existing assessments https://bit.ly/3a6Ha41

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Breathe (Sheff)
Asıl Yazarlar: Guariglia, Andrea, Davies, Iona J., Kanellakis, Nikolaos I.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: European Respiratory Society 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7792827/
https://ncbi.nlm.nih.gov/pubmed/33447290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0204-2020
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!